| 000 | 01718 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515153936.0 | ||
| 264 | 0 | _c20090417 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdn734 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReckova, M | |
| 245 | 0 | 0 |
_aTreatment of hemodialyzed patient with sunitinib. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cFeb 2009 |
||
| 300 |
_a392-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Comment | ||
| 650 | 0 | 4 |
_aAnemia _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xsurgery |
| 650 | 0 | 4 |
_aCoronary Artery Bypass _xmethods |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aKakalejcik, M | |
| 700 | 1 | _aBeniak, J | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 20 _gno. 2 _gp. 392-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdn734 _zAvailable from publisher's website |
| 999 |
_c18584718 _d18584718 |
||